Khalid Ahmed

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

Peter Nash, Bruce Kirkham, Masato Okada et al. · The Lancet · 2017 · 390 citations · Full text

Rheumatoid Disorder, Rheumatology, Spirit-p2 Phase 3 +12

Patterns and management of degloving injuries: a single national level 1 trauma center experience

Suhail Hakim, Khalid Ahmed, Ayman El‐Menyar et al. · World Journal of Emergency Surgery · 2016 · 53 citations · Full text

Epidemiological and clinical characteristics of fall-related injuries: a retrospective study

Ahammed Mekkodathil, Ayman El‐Menyar, Ahad Kanbar et al. · BMC Public Health · 2020 · 49 citations · Full text

Thymulin Modulates Cytokine Release by Peripheral Blood Mononuclear Cells: A Comparison between Healthy Volunteers and Patients with Systemic Lupus Erythematosus

Bared Safieh‐Garabedian, Khalid Ahmed, Munther A. Khamashta et al. · International Archives of Allergy and Immunology · 1993 · 44 citations

Immunology, Immature Precursors, Immunotherapy +16

The short musculoskeletal functional assessment (SMFA) score amongst surgical patients with reconstructive lower limb injuries in war wounded civilians

Carrie Teicher, Nancy L. Foote, Ali M. K. Al Ani et al. · Injury · 2014 · 42 citations

Limb Reconstruction, Lower Limb Trauma, Upper Extremity +7